Daejeon, South Korea

Jae-Kwang Yoo

This inventor holds 1 USPTO granted patent. Top assignee: Ilias Biologics Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae-Kwang Yoo. Retrieved from https://idiyas.com/inventor/jae-kwang-yoo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jae-Kwang Yoo

Introduction

Jae-Kwang Yoo is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the area of drug delivery systems. His innovative work focuses on utilizing exosome-based methods to enhance the delivery of therapeutic agents.

Latest Patents

Jae-Kwang Yoo holds a patent titled "Use of Exosome-Based Delivery of NF-KB Inhibitors." This patent represents a breakthrough in the application of exosomes for targeted therapy, which could potentially improve treatment outcomes for various diseases.

Career Highlights

Throughout his career, Yoo has been associated with Ilias Biologics Inc., a company dedicated to advancing biopharmaceutical technologies. His work at Ilias Biologics has positioned him as a key player in the development of novel therapeutic strategies.

Collaborations

Yoo has collaborated with esteemed colleagues, including Chulhee Choi and Kyungsun Choi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jae-Kwang Yoo's contributions to biotechnology through his patent and work at Ilias Biologics Inc. highlight his role as an influential inventor in the field. His innovative approaches continue to pave the way for advancements in drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…